Fluorometric estimation of taurine in tissue extracts and biological fluids

A fluorometric technique was developed to estimate taurine in tissue extracts and body fluids. Dowex-AG and Biorad-AG columns were used to separate this amino acid from other components. Interference by Glycerophosphoryl ethanolamine was removed by hydrolysis of the sample with 6N HCl. The fluorogen used was fluorescamine.     

Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli

Background  

Efflux pump activity has been associated with multidrug resistance phenotypes in bacteria, compromising the effectiveness of antimicrobial therapy. The development of methods for the early detection and quantification of drug transport across the bacterial cell wall is a tool essential to understand and overcome this type of drug resistance mechanism. This approach was developed to study the transport of the efflux pump substrate ethidium bromide (EtBr) across the cell envelope of Escherichia coli K-12 and derivatives, differing in the expression of their efflux systems.     

Enzymatic determination of dehydroepiandrosterone sulfate in biological fluids

A simple method is described for the determination of androgens, particularly dehydroepiandrosterone sulfate (DHEAS), in human plasma and urine. The method does not involve extraction or chromatography. An internal standard is used as reference. The androgens are enzymatically converted to estrogens and these latter compounds can be measured by the enzymatic method previously described [1]. The range of accuracy was between 99 and 103%. The precision of the method was 2.5%. The sensitivity was 0.1 pM per sample. The method is suitable for routine use, and one worker can easily perform twenty assays in one day.     

High-performance liquid chromatographic determination of sotalol in biological fluids

A sensitive, selective and reproducible reversed-phase high-performance liquid chromatographic method is described for the quantification of sotalol in human serum and urine. Sotalol and the internal standard, atenolol, were extracted from alkalinized serum and urine (pH 9.0) into 1-butanol—chloroform (20:60, v/v). The organic phase was evaporated, and to the residue was added 0.1 M sulphuric acid (serum analysis) or mobile phase (urie analysis). The mobile phase consisted of 0.01 M phosphate buffer (pH 3.2) and acetonitrile (20:80, v/v) containing 3 mM n-octylsodium sulphate. The flow-rate was 1.5 ml/min. The retention times of atenolol and sotalol were 7 and 10 min, respectively. Ultraviolet detection at 226 nm made it possible to achieve a detection limit of 0.03 μmol/l.     

Fluorometric determination of selenium in nanogram amounts in biological materials using 2,3-diaminonaphthalene

Nanogram amounts of selenium in biological material were determined fluorometrically using 2,3-diaminonaphthalene after digestion with nitric-perchloric acids. Linear relationship between fluorescence and selenium concentration held within 100 ng of selenium, and the experimental scattering was less than 4% for a range from 5 to 25 ng of selenium. A recovery of 99 ± 5% was achieved for 2.5 ng of selenium preadded to tuna muscle extract. The method is characterized by simple procedures and is suited for small quantities of samples.     

Voltammetric determination of cefixime in pharmaceuticals and biological fluids

Electroreduction and adsorption of cefixime was studied in phosphate buffer by cyclic voltammetry (CV), differential pulse cathodic adsorptive stripping voltammetry (DPCAdSV), and square-wave cathodic adsorptive stripping voltammetry (SWCAdSV) at hanging mercury drop electrode (HMDE). These fully validated sensitive and reproducible cathodic adsorptive stripping voltammetric procedures were applied for the trace determination of the bulk drug in pharmaceutical formulations and in human urine. The optimal experimental parameters were as follows: accumulation potential = −0.1 V (vs. Ag/AgCl, 3 M KCl), accumulation time = 50 s, frequency = 140 Hz, pulse amplitude = 0.07 V, and scan increment = 10 mV in phosphate buffer (pH 2.6). The first peak current showed a linear dependence with the drug concentration over the range of 50 ng ml⁻¹ to 25.6 μg ml⁻¹. The achieved limit of detection and limit of quantitation were 3.99 and 13.3 ng ml⁻¹ by SWCAdSV and 7.98 and 26.6 ng ml⁻¹ by DPCAdSV, respectively. The procedure was applied to assay the drug in tablets. Applicability was also tested in urine samples. Peak current was linear with the drug concentration in the range of 1 to 60 μg ml⁻¹ of the urine, and minimum detectability was found to be 12.6 ng ml⁻¹ by SWCAdSV and 58.4 ng ml⁻¹ by DPCAdSV.